Literature DB >> 33861685

Associations of D-Dimer with Computed Tomographic Lung Abnormalities, Serum Biomarkers of Lung Injury, and Forced Vital Capacity: MESA Lung Study.

John S Kim1,2, Michaela R Anderson2, Elana J Bernstein2, Elizabeth C Oelsner2, Ganesh Raghu3, Imre Noth1, Michael Y Tsai4, Mary Salvatore5, John H M Austin5, Eric A Hoffman6, R Graham Barr2,7, Anna J Podolanczuk2,8.   

Abstract

Rationale: The coagulation cascade may play a role in the pathogenesis of interstitial lung disease through increased production of thrombin and fibrin deposition. Whether circulating coagulation cascade factors are linked to lung inflammation and scarring among community-dwelling adults is unknown.
Objectives: To test the hypothesis that higher baseline D-dimer concentrations are associated with markers of early lung injury and scarring.
Methods: Using the MESA (Multi-Ethnic Study of Atherosclerosis) cohort (n = 6,814), we examined associations of baseline D-dimer concentrations with high attenuation areas from examination 1 (2000-2002; n = 6,184) and interstitial lung abnormalities from examination 5 computed tomographic (CT) scans (2010-2012; n = 2,227), and serum MMP-7 (matrix metalloproteinase-7) and SP-A (surfactant protein-A) from examination 1 (n = 1,098). We examined longitudinal change in forced vital capacity (FVC) from examinations 3-6 (2004-2018, n = 3,562). We used linear logistic regression and linear mixed models to examine associations and adjust for potential confounders.
Results: The mean (standard deviation) age of the cohort was 62 (10) years, and the D-dimer concentration was 0.35 (0.69) ug/ml. For every 10% increase in D-dimer concentration, there was an increase in high attenuation area percentage of 0.27 (95% confidence interval (CI), 0.08-0.47) after adjustment for covariates. Associations were stronger among those older than 65 years (P values for interaction < 0.001). A 10% increase in D-dimer concentration was associated with an odds ratio of 1.05 for interstitial lung abnormalities (95% CI, 0.99-1.11). Higher D-dimer concentrations were associated with higher serum MMP-7 and a faster decline in FVC. D-dimer was not associated with SP-A. Conclusions: Higher D-dimer concentrations were associated with a greater burden of lung parenchymal abnormalities detected on CT scan, MMP-7, and FVC decline among community-dwelling adults.

Entities:  

Keywords:  D-dimer; coagulation cascade; interstitial lung disease; lung function; smoking

Mesh:

Substances:

Year:  2021        PMID: 33861685      PMCID: PMC8641831          DOI: 10.1513/AnnalsATS.202012-1557OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  42 in total

1.  Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality.

Authors:  Aaron R Folsom; Joseph A C Delaney; Pamela L Lutsey; Neil A Zakai; Nancy S Jenny; Joseph F Polak; Mary Cushman
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

2.  Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study.

Authors:  David J Lederer; Paul L Enright; Steven M Kawut; Eric A Hoffman; Gary Hunninghake; Edwin J R van Beek; John H M Austin; Rui Jiang; Gina S Lovasi; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2009-06-19       Impact factor: 21.405

Review 3.  Subclinical interstitial lung disease: why you should care.

Authors:  Tracy J Doyle; Gary M Hunninghake; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2012-02-23       Impact factor: 21.405

4.  High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study.

Authors:  Anna J Podolanczuk; Elizabeth C Oelsner; R Graham Barr; Eric A Hoffman; Hilary F Armstrong; John H M Austin; Robert C Basner; Matthew N Bartels; Jason D Christie; Paul L Enright; Bernadette R Gochuico; Karen Hinckley Stukovsky; Joel D Kaufman; P Hrudaya Nath; John D Newell; Scott M Palmer; Dan Rabinowitz; Ganesh Raghu; Jessica L Sell; Jered Sieren; Sushil K Sonavane; Russell P Tracy; Jubal R Watts; Kayleen Williams; Steven M Kawut; David J Lederer
Journal:  Eur Respir J       Date:  2016-07-28       Impact factor: 16.671

5.  Association Between Anticoagulation and Survival in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Patient Registry.

Authors:  Christopher S King; Elizabeth Freiheit; A Whitney Brown; Oksana A Shlobin; Shambhu Aryal; Kareem Ahmad; Vikramjit Khangoora; Kevin R Flaherty; Drew Venuto; Steven D Nathan
Journal:  Chest       Date:  2020-10-16       Impact factor: 9.410

6.  Laboratory methods and quality assurance in the Cardiovascular Health Study.

Authors:  M Cushman; E S Cornell; P R Howard; E G Bovill; R P Tracy
Journal:  Clin Chem       Date:  1995-02       Impact factor: 8.327

7.  Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.

Authors:  David C J Howell; Robin H Johns; Joseph A Lasky; Bin Shan; Chris J Scotton; Geoffrey J Laurent; Rachel C Chambers
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

8.  Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro.

Authors:  S C Robson; E G Shephard; R E Kirsch
Journal:  Br J Haematol       Date:  1994-02       Impact factor: 6.998

9.  Associations between fibrin D-dimer, markers of inflammation, incident self-reported mobility limitation, and all-cause mortality in older men.

Authors:  S Goya Wannamethee; Peter H Whincup; Lucy Lennon; Olia Papacosta; Gordon D Lowe
Journal:  J Am Geriatr Soc       Date:  2014-12       Impact factor: 5.562

10.  Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.

Authors:  George Goshua; Alexander B Pine; Matthew L Meizlish; C-Hong Chang; Hanming Zhang; Parveen Bahel; Audrey Baluha; Noffar Bar; Robert D Bona; Adrienne J Burns; Charles S Dela Cruz; Anne Dumont; Stephanie Halene; John Hwa; Jonathan Koff; Hope Menninger; Natalia Neparidze; Christina Price; Jonathan M Siner; Christopher Tormey; Henry M Rinder; Hyung J Chun; Alfred I Lee
Journal:  Lancet Haematol       Date:  2020-06-30       Impact factor: 18.959

View more
  1 in total

1.  Clinical and Immunological Markers of Pulmonary Impairment Among People With HIV in India.

Authors:  Anurima Baidya; Shashikala Sangle; Ivan Marbaniang; Vandana Kulkarni; Prasad Deshpande; Smita Nimkar; Amol Chavan; Sonali Salvi; Rahul Lokhande; Dileep Kadam; Amita Gupta; Vidya Mave; Akshay N Gupte
Journal:  Open Forum Infect Dis       Date:  2022-05-11       Impact factor: 4.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.